These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35579012)

  • 1. Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women.
    Giovenco D; Pettifor A; Powers KA; Hightow-Weidman L; Pence BW; Celum C; Delany-Moretlwe S; Hosek S; Donnell D; Anderson PL; Mgodi N; Bekker LG
    AIDS; 2022 Jul; 36(8):1151-1159. PubMed ID: 35579012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre-exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial.
    Velloza J; Hosek S; Donnell D; Anderson PL; Chirenje M; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
    J Int AIDS Soc; 2021 Jun; 24 Suppl 2(Suppl 2):e25731. PubMed ID: 34164929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster-randomized trial.
    Roberts ST; Hartmann M; Minnis AM; Otticha SO; Browne EN; Montgomery ET; Agot K
    J Int AIDS Soc; 2023 Dec; 26(12):e26198. PubMed ID: 38123866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial.
    Celum CL; Gill K; Morton JF; Stein G; Myers L; Thomas KK; McConnell M; van der Straten A; Baeten JM; Duyver M; Mendel E; Naidoo K; Dallimore J; Wiesner L; Bekker LG
    J Int AIDS Soc; 2020 Nov; 23(11):e25636. PubMed ID: 33247553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
    Celum CL; Delany-Moretlwe S; Baeten JM; van der Straten A; Hosek S; Bukusi EA; McConnell M; Barnabas RV; Bekker LG
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of intimate partner violence on PrEP adherence among U.S. Cisgender women at risk for HIV.
    Anderson KM; Blumenthal J; Jain S; Sun X; Amico KR; Landovitz R; Zachek CM; Morris S; Moore DJ; Stockman JK
    BMC Public Health; 2024 May; 24(1):1461. PubMed ID: 38822300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
    Tapsoba JD; Cover J; Obong'o C; Brady M; Cressey TR; Mori K; Okomo G; Kariithi E; Obanda R; Oluoch-Madiang D; Chen YQ; Drain P; Duerr A
    PLoS Med; 2022 Sep; 19(9):e1004097. PubMed ID: 36095005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
    Celum C; Hosek S; Tsholwana M; Kassim S; Mukaka S; Dye BJ; Pathak S; Mgodi N; Bekker LG; Donnell DJ; Wilson E; Yuha K; Anderson PL; Agyei Y; Noble H; Rose SM; Baeten JM; Fogel JM; Adeyeye A; Wiesner L; Rooney J; Delany-Moretlwe S
    PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.
    Roberts ST; Haberer J; Celum C; Mugo N; Ware NC; Cohen CR; Tappero JW; Kiarie J; Ronald A; Mujugira A; Tumwesigye E; Were E; Irungu E; Baeten JM;
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):313-322. PubMed ID: 27243900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of PrEP Use Disclosure on Adherence in a Cohort of Adolescent Girls and Young Women in South Africa.
    Giovenco D; Pettifor A; Powers KA; Hightow-Weidman L; Pence BW; Edwards JK; Gill K; Morton JF; van der Straten A; Celum C; Bekker LG
    AIDS Behav; 2022 Apr; 26(4):1007-1016. PubMed ID: 34478015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
    Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
    J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trial.
    Velloza J; Poovan N; Ndlovu N; Khoza N; Morton JF; Omony J; Mkwanazi E; Grabow C; Donnell D; Munthali R; Baeten JM; Hosek S; Celum C; Delany-Moretlwe S
    PLoS One; 2022; 17(4):e0266665. PubMed ID: 35417485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
    Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study.
    Beauchamp G; Hosek S; Donnell DJ; Chan KCG; Flaherty BP; Anderson PL; Dye BJ; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
    PLoS One; 2023; 18(2):e0281728. PubMed ID: 36827440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial.
    Velloza J; Donnell D; Hosek S; Anderson PL; Chirenje ZM; Mgodi N; Bekker LG; Marzinke MA; Delany-Moretlwe S; Celum C
    Lancet HIV; 2022 Oct; 9(10):e680-e689. PubMed ID: 36087612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial.
    Ngure K; Browne EN; Reddy K; Friedland BA; van der Straten A; Palanee-Phillips T; Nakalega R; Gati B; Kalule HN; Siziba B; Soto-Torres L; Nair G; Garcia M; Celum C; Roberts ST
    AIDS Behav; 2024 Sep; 28(9):2990-3000. PubMed ID: 38852114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Buzibye A; Omali D; Chinyenze K; Kuteesa M; Kaleebu P; Price MA
    J Int AIDS Soc; 2022 May; 25(5):e25909. PubMed ID: 35543110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence.
    Giovenco D; Gill K; Fynn L; Duyver M; O'Rourke S; van der Straten A; Morton JF; Celum CL; Bekker LG
    PLoS One; 2021; 16(3):e0248307. PubMed ID: 33667264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study.
    Beauchamp G; Donnell D; Hosek S; Anderson PL; Chan KCG; Dye BJ; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C
    BMC Womens Health; 2023 May; 23(1):276. PubMed ID: 37208687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.